1,571
Views
1
CrossRef citations to date
0
Altmetric
Coronavirus – Research Article

Current status of coronavirus disease 2019 vaccine research based on bibliometric analysis

, , , , & ORCID Icon
Article: 2119766 | Received 23 Jun 2022, Accepted 29 Aug 2022, Published online: 15 Sep 2022

References

  • WHO. Director-general’s opening remarks at the media briefing on COVID-19 - 11 March 2020. [accessed 2022 April 7]. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020.
  • Moradian N, Ochs HD, Sedikies C, Hamblin MR, Camargo CA, Martinez JA, Biamonte JD, Abdollahi M, Torres PJ, Nieto JJ, et al. The urgent need for integrated science to fight COVID-19 pandemic and beyond. J Transl Med. 2020;18(1):1. doi:10.1186/s12967-020-02364-2.
  • Moradian N, Moallemian M, Delavari F, Sedikides C, Camargo CA, Torres PJ, Sorooshian A, Mehdiabadi SP, Nieto JJ, Bordas S, et al. Interdisciplinary approaches to COVID-19, Adv exp med biol. 2021;1318:923–12. doi:10.1007/978-3-030-63761-3_52.
  • Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCov) in vitro. Cell Res. 2020;30(3):269–271. doi:10.1038/s41422-020-0282-0.
  • Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19. N Engl J Med. 2020;382(19):1787–1799. doi:10.1056/NEJMoa2001282.
  • Gao J, Tian Z, Yang X. Breakthrough: chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020;14(1):72–73. doi:10.5582/bst.2020.01047.
  • Campos DMO, Fulco UL, de Oliveira CBS, Oliveira JIN. SARS-CoV-2 virus infection: targets and antiviral pharmacological strategies. J Evid Based Med. 2020;13(4):255–260. doi:10.1111/jebm.12414.
  • Twomey JD, Luo S, Dean AQ, Bozza WP, Nalli A, Zhang B. COVID-19 update: the race to therapeutic development. Drug Resist Updat. 2020;53:100733. doi:10.1016/j.drup.2020.100733.
  • Leng Z, Zhu R, Hou W, Feng Y, Yang Y, Han Q, Shan G, Meng F, Du D, Wang S, et al. Transplantation of ACE2(-) mesenchymal stem cells improves the outcome of patients with COVID-19 pneumonia. Aging Dis. 2020;11(2):216–228. doi:10.14336/ad.2020.0228.
  • Xing Y, Mo P, Xiao Y, Zhao O, Zhang Y, Wang F. Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020. Euro Surveillance : Bulletin Euro Sur Les Maladies Transmissibles = Euro Commun Dis Bulletin. 2020;25(10). doi:10.2807/1560-7917.Es.2020.25.10.2000191.
  • Su Z, McDonnell D, Li X, Bennett B, Šegalo S, Abbas J, Cheshmehzangi A, Xiang YT. COVID-19 vaccine donations-vaccine empathy or vaccine diplomacy? A narrative literature review. Vaccines. 2021;9. doi:10.3390/vaccines9091024.
  • Basak P, Abir T, Al Mamun A, Zainol NR, Khanam M, Haque MR, Milton AH, Agho KE. A global study on the correlates of gross domestic product (GDP) and COVID-19 vaccine distribution. Vaccines. 2022;10(2). doi:10.3390/vaccines10020266.
  • Ahn DG, Shin HJ, Kim MH, Lee S, Kim H-S, Myoung J, Kim B-T, Kim S-J. Current status of epidemiology, diagnosis, therapeutics, and vaccines for novel coronavirus disease 2019 (COVID-19. J Microbiol Biotechnol. 2020;30(3):313–324. doi:10.4014/jmb.2003.03011.
  • Graham BS. Rapid COVID-19 vaccine development. Science (New York, NY). 2020;368(6494):945–946. doi:10.1126/science.abb8923.
  • WHO. Coronavirus disease (COVID-2019) situation reports. https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
  • Zimmer C, Corum J, Wee SL. COVID-19 vaccine tracker. [accessed 2022 April 7]. https://covid19.trackvaccines.org/vaccines/approved/.
  • Ellegaard O, Wallin JA. The bibliometric analysis of scholarly production: how great is the impact? Scientometrics. 2015;105(3):1809–1831. doi:10.1007/s11192-015-1645-z.
  • Martín-Martín A, Thelwall M, Orduna-Malea E, Delgado López-Cózar E. Google Scholar, Microsoft Academic, Scopus, dimensions, Web of Science, and opencitations’ COCI: a multidisciplinary comparison of coverage via citations. Scientometrics. 2020:1–36. doi:10.1007/s11192-020-03690-4.
  • Hou Q, Mao G, Zhao L, Du H, Zuo JJIJOLCA. Mapping the scientific research on life cycle assessment: a bibliometric analysis. Int J Life Cycle Assess. 2015;20:541–555. https://doi.org/10.1007/s11367-015-0846-2.
  • Falagas ME, Pitsouni EI, Malietzis GA, Pappas G. Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J. 2008;22(2):338–342. doi:10.1096/fj.07-9492LSF.
  • Chen S, Lu Q, Bai J, Deng C, Wang Y, Zhao Y. Global publications on stigma between 1998-2018: a bibliometric analysis. J Affect Disord. 2020;274:363–371. doi: 10.1016/j.jad.2020.05.006.
  • van Eck NJ, Waltman L. Software survey: vOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523–538. doi:10.1007/s11192-009-0146-3.
  • Chen C. Searching for intellectual turning points: progressive knowledge domain visualization. Proc Natl Acad Sci U S A. 2004;101(Suppl 1):5303–5310. doi:10.1073/pnas.0307513100.
  • Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 2020;383(27):2603–2615. doi:10.1056/NEJMoa2034577.
  • Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384(5):403–416. doi:10.1056/NEJMoa2035389.
  • Garcia-Beltran WF, St Denis KJ, Hoelzemer A, Lam EC, Nitido AD, Sheehan ML, Berrios C, Ofoman O, Chang CC, Hauser BM, et al. mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 omicron variant. Cell. 2022;185(3):e454. doi:10.1016/j.cell.2021.12.033.
  • Ahmad T, Murad MA, Baig M, Hui J. Research trends in COVID-19 vaccine: a bibliometric analysis. Hum Vaccines Immunotherapeutics. 2021;17(8):2367–2372. doi:10.1080/21645515.2021.1886806.
  • Xu Z, Qu H, Ren Y, Gong Z, Ri HJ, Zhang F, Chen X, Zhu W, Shao S, Chen X, et al. Update on the COVID-19 vaccine research trends: a bibliometric analysis. Infect Drug Resist. 2021;14:4237–4247. doi:10.2147/idr.S335745.
  • Fisher KA, Bloomstone SJ, Walder J, Crawford S, Fouayzi H, Mazor KM. Attitudes toward a potential SARS-CoV-2 vaccine : a survey of U.S. adults. Ann Intern Med. 2020;173(12):964–973. doi:10.7326/m20-3569.
  • Xu Y, Zhang R, Zhou Z, Fan J, Liang J, Cai L, Peng L, Ren F, Lin W. Parental psychological distress and attitudes towards COVID-19 vaccination: a cross-sectional survey in Shenzhen, China. J Affect Disord. 2021;292:552–558. doi: 10.1016/j.jad.2021.06.003.
  • Wang Q, Yang L, Jin H, Lin L. Vaccination against COVID-19: a systematic review and meta-analysis of acceptability and its predictors. Prev Med. 2021;150:106694. doi:10.1016/j.ypmed.2021.106694.
  • Lu X, Lu C, Yang Y, Shi X, Wang H, Yang N, Yang K, Zhang X. Current status and trends in peptide receptor radionuclide therapy in the past 20 years (2000-2019): a bibliometric study. Front Pharmacol. 2021;12:624534. doi: 10.3389/fphar.2021.624534.
  • Lu C, Liu M, Shang W, Yuan Y, Li M, Deng X, Li H, Yang K. Knowledge mapping of angelica sinensis (Oliv.) Diels (Danggui) research: a scientometric study. Front Pharmacol. 2020;11:294. doi: 10.3389/fphar.2020.00294.
  • Voysey M, Clemens SAC, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, Barnabas SL, Bhorat QE, et al. Safety and efficacy of the ChAdox1 nCov-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet (London, England). 2021;397(10269):99–111. doi:10.1016/s0140-6736(20)32661-1.